JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Fujii, Y. Articles by Toyooka, H. Search for Related Content PubMed PubMed Citation Articles by Fujii, Y. Articles by Toyooka, H.

---

GENERAL ARTICLES

Comparison of Ramosetron and Granisetron for Preventing Postoperative Nausea and Vomiting After Gynecologic Surgery

Yoshitaka Fujii, MD^*, Yuhji Saitoh, MD, Hiroyoshi Tanaka, MD, and Hidenori Toyooka, MD^*

Departments of Anesthesiology, *University of Tsukuba Institute of Clinical Medicine, Tsukuba City; and Toride Kyodo General Hospital, Toride City, Ibaraki, Japan

Address correspondence and reprint requests to Y. Fujii, Department of Anesthesiology, University of Tsukuba Institute of Clinical Medicine, 2–1-1, Amakubo, Tsukuba City, Ibaraki 305, Japan.

In a prospective, randomized, double-blinded study, we evaluated the efficacy of granisetron and ramosetron for preventing postoperative nausea and vomiting (PONV) in major gynecologic surgery. One hundred twenty patients, ASA physical status I or II, aged 23–65 yr, received IV granisetron 2.5 mg or ramosetron 0.3 mg (n = 60 each) at the end of surgery. A standard general anesthetic technique and postoperative analgesia were used. The incidence of a complete response, defined as no PONV and no need for another rescue medication, 0–3 h after anesthesia was 87% with granisetron and 90% with ramosetron; the corresponding incidence 3–24 h after anesthesia was 85% and 90%; the corresponding incidence 24–48 h after anesthesia was 70% and 92% (P < 0.05). No clinically serious adverse events due to the drugs were observed in any of the groups. In conclusion, prophylactic therapy with ramosetron is more effective than granisetron for the long-term prevention of PONV after major gynecologic surgery.

Implications: We compared the efficacy of granisetron and ramosetron for preventing postoperative nausea and vomiting in major gynecologic surgery. Prophylactic therapy with ramosetron was more effective than granisetron for preventing postoperative nausea and vomiting 24–48 h after anesthesia.

This article has been cited by other articles:

				A. S. Habib and T. J. Gan Evidence-based management of postoperative nausea and vomiting: a review: [Le traitement des nausees et des vomissements postoperatoires fonde sur des donnees probantes : une revue] Can J Anesth, April 1, 2004; 51(4): 326 - 341. [Abstract] [Full Text] [PDF]

				Y. Fujii, H. Tanaka, and M. Ito Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children Br. J. Ophthalmol., June 1, 2001; 85(6): 670 - 672. [Abstract] [Full Text] [PDF]

				P. Kranke, C. C. Apfel, N. Roewer, and Y. Fujii Reported Data on Granisetron and Postoperative Nausea and Vomiting by Fujii et al. Are Incredibly Nice! • Response Anesth. Analg., April 1, 2000; 90(4): 1004 - 1007. [Full Text] [PDF]

				Y. Fujii, Y. Saitoh, H. Tanaka, and H. Toyooka Ramosetron for Preventing Postoperative Nausea and Vomiting in Women Undergoing Gynecological Surgery Anesth. Analg., February 1, 2000; 90(2): 472 - 472. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999